Akero Therapeutics(AKRO.US)

Last Updated 19:00:00 ET
longbridge loading

22:54 ETCadonilimab Combination Demonstrates Promising Survival Benefit in Locally Advanced Pancreatic Cancer: Phase II COMPASSION-26 Data Presented at AACR 2026

prnewswire·
US
AKRO
0.00%
US
XBI
+3.88%
US
BBH
+0.96%
prnewswire·
US
AKRO
0.00%
US
XBI
+3.88%
US
BBH
+0.96%

16:13 ETAre KZR, EQH, ULYX Obtaining Fair Deals for their Shareholders?

prnewswire·
US
ULY
0.00%
US
EQH
+2.79%
US
CRBG
+3.07%
prnewswire·
US
ULY
0.00%
US
EQH
+2.79%
US
CRBG
+3.07%

23:28 ETAkeso Presents Updated Data on Cadonilimab Combination Therapy in PD-(L) 1 Inhibitor-Resistant Advanced NSCLC at ELCC 2026

prnewswire·
US
BIS
-4.67%
US
LABU
+11.76%
US
BIB
+4.98%
prnewswire·
US
BIS
-4.67%
US
LABU
+11.76%
US
BIB
+4.98%

05:40 ETIvonescimab Shows Quality of Life Benefits in Chemotherapy-Free First-Line NSCLC: Health-Related Quality of Life Data from the HARMONi-2 Study Presented at ELCC 2026

prnewswire·
US
SBIO
+3.75%
US
VHT
+0.27%
US
BBH
+0.96%
prnewswire·
US
SBIO
+3.75%
US
VHT
+0.27%
US
BBH
+0.96%

22:05 ETAkeso Announces Global First-in-Class Trispecific Antibody AK150 Enters Clinical Trials: A Triple-Target Approach to Overcome Immunotherapy Resistance

prnewswire·
US
FBT
+2.14%
US
XBI
+3.88%
US
BIB
+4.98%
prnewswire·
US
FBT
+2.14%
US
XBI
+3.88%
US
BIB
+4.98%

Aker BioMarine Registers Share Capital Increase from Employee Share Program

Tip Ranks·
US
BBH
+0.96%
US
ARKG
+5.05%
US
IBB
+2.27%
Tip Ranks·
US
BBH
+0.96%
US
ARKG
+5.05%
US
IBB
+2.27%

21:59 ETACROBiosystems fördert Innovationen bei JPM Spotlight-Sessions von bioSeedin und unterstützt strategisch den Aufbau globaler Partnerschaften

prnewswire·
US
BIB
+4.98%
US
ARKG
+5.05%
US
SBIO
+3.75%
prnewswire·
US
BIB
+4.98%
US
ARKG
+5.05%
US
SBIO
+3.75%

Agomab Announces Launch of Initial Public Offering

fidelity·
US
APGE
+3.99%
US
NLSP
0.00%
US
SBIO
+3.75%
fidelity·
US
APGE
+3.99%
US
NLSP
0.00%
US
SBIO
+3.75%
© 2026 Longbridge｜Disclaimer